- Home
- MRVI vs DSM Comparison
MRVI vs DSM Comparison
Compare MRVI & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- DSM
- Stock Information
- Founded
- MRVI 2014
- DSM 1989
- Country
- MRVI United States
- DSM United States
- Employees
- MRVI N/A
- DSM N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- MRVI Health Care
- DSM Finance
- Exchange
- MRVI Nasdaq
- DSM Nasdaq
- Market Cap
- MRVI 262.9M
- DSM 270.9M
- IPO Year
- MRVI 2020
- DSM N/A
- Fundamental
- Price
- MRVI $1.98
- DSM $5.75
- Analyst Decision
- MRVI Hold
- DSM
- Analyst Count
- MRVI 9
- DSM 0
- Target Price
- MRVI $6.54
- DSM N/A
- AVG Volume (30 Days)
- MRVI 1.6M
- DSM 161.7K
- Earning Date
- MRVI 05-12-2025
- DSM 01-01-0001
- Dividend Yield
- MRVI N/A
- DSM 3.97%
- EPS Growth
- MRVI N/A
- DSM N/A
- EPS
- MRVI N/A
- DSM N/A
- Revenue
- MRVI $259,185,000.00
- DSM N/A
- Revenue This Year
- MRVI N/A
- DSM N/A
- Revenue Next Year
- MRVI $14.23
- DSM N/A
- P/E Ratio
- MRVI N/A
- DSM N/A
- Revenue Growth
- MRVI N/A
- DSM N/A
- 52 Week Low
- MRVI $1.67
- DSM $4.69
- 52 Week High
- MRVI $11.56
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- MRVI 43.17
- DSM 60.00
- Support Level
- MRVI $1.96
- DSM $5.63
- Resistance Level
- MRVI $2.16
- DSM $5.74
- Average True Range (ATR)
- MRVI 0.13
- DSM 0.07
- MACD
- MRVI 0.04
- DSM 0.04
- Stochastic Oscillator
- MRVI 47.67
- DSM 94.74
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.